Product Theater Registration
Thursday, October 17, 2024
12:00 – 1:00 pm
John Fezza, MD
Center for Sight
Join Nordic Pharma, Inc. as our presenters discuss LACRIFILL® Canalicular Gel, an interventional dry eye treatment that is changing practice and changing lives. LACRIFILL is reimbursement-ready using CPT Code 68761. This cross-linked hyaluronic acid gel allows patient’s eyes to be bathed in their own natural tears. LACRIFILL is customized for each patient, provides a full fill of the canalicular system and remains in place until removal at 6 months. Don’t miss this session so you too can step into the future of dry eye intervention.
This event is not planned or endorsed by ASOPRS.